Buscar

Mostrando ítems 1-10 de 46952

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Ma, Cuiqing; Su, Shan; Wang, Jiachao; Wei, Lin; Du, Lanying; Jiang, Shibo

The global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and HCoV-19) has posed serious threats to public health and economic stability worldwide, thus calling for development of vaccines against ...

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Zhou, Yadi; Hou, Yuan; Shen, Jiayu; Huang, Yin; Martin, William; Cheng, Feixiong

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, ...

Insight into 2019 novel coronavirus: an updated interim review and lessons from SARS-CoV and MERS-CoV

Xie, Mingxuan; Chen, Qiong (Elsevier, 2020)

Potential treatment methods targeting 2019-nCoV infection

Zheng, Lu; Zhang, Lina; Huang, Jiamin; Selva Nandakumar, Kutty; Liu, Shuwen; Cheng, Kui

The novel coronavirus, 2019-nCoV, has quickly spread across the world and pose serious threat to public health because it can infect people very easily. The major clinical symptoms of 2019-nCoV infection include fever, dry ...

Potential treatment methods targeting 2019-nCoV infection

Zheng, Lu; Zhang, Lina; Huang, Jiamin; Nandakumar, Kutty Selva; Liu, Shuwen; Cheng, Kui

The 2019-nCoV pandemic in the global south: a tsunami ahead

Malta, Monica; Rimoin, Anne W.; Hoff, Nicole A.; Strathdee, Steffanie A. (Elsevier, 2020)

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Xia, Shuai; Liu, Meiqin; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu Lu

1
2
3
4
. . .
4696

Buscar

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Insight into 2019 novel coronavirus: an updated interim review and lessons from SARS-CoV and MERS-CoV

Potential treatment methods targeting 2019-nCoV infection

Potential treatment methods targeting 2019-nCoV infection

The 2019-nCoV pandemic in the global south: a tsunami ahead

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Boletín diario de información científica N° 1

Boletín diario de información científica N° 8

Boletín diario de información científica N° 11

Buscar

Filtros

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Insight into 2019 novel coronavirus: an updated interim review and lessons from SARS-CoV and MERS-CoV

Potential treatment methods targeting 2019-nCoV infection

Potential treatment methods targeting 2019-nCoV infection

The 2019-nCoV pandemic in the global south: a tsunami ahead

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Boletín diario de información científica N° 1

Boletín diario de información científica N° 8

Boletín diario de información científica N° 11